Kang, Jin-Hyoung
Lee, Ki-Hyeong
Kim, Dong-Wan
Kim, Sang-We
Kim, Hye Ryun
Kim, Joo-Hang
Choi, Jin-Hyuk
An, Ho Jung
Kim, Jin-Soo
Jang, Joung-Soon
Kim, Bong-Seog
Kim, Heung Tae
Funding for this research was provided by:
Chung Kun Dang Pharmaceutical Corp.
Article History
Received: 29 December 2019
Revised: 30 July 2020
Accepted: 24 August 2020
First Online: 16 November 2020
Ethics approval and consent to participate
: The study was conducted in accordance with the principles of the Declaration of Helsinki. It was registered with ClinicalTrials.gov (NCT01497873) and approved by the Institutional Review Board (IRB) of each participating institution (individual IRB committees are listed in the Supplementary File). All participants gave their informed consent prior to study inclusion.
: The data are available for all study authors. The datasets used and analysed during the current study are available from the corresponding author on reasonable request.
: The authors declare no competing financial interests.
: This work was sponsored by Chong Kun Dang Pharmaceutical Corp., Seoul, South Korea.